Total Fat: 14g
A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes
These mechanisms are responsible for the appetite suppression that drives weight loss but they also explain why the most common side effects involve the digestive system
PlexusDx recommends documenting your injection date in your phone calendar and sharing it with a family member or healthcare provider for accountability
Suicidality: under active investigation Regulatory bodies, including the European Medicines Agency, have been reviewing a potential association between GLP-1 drugs and suicidal ideation